Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- AI Summary
- About
MPLN 
MultiPlan Corporation (MPLN)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/14/2025: MPLN (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -42.19% | Avg. Invested days 17 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 01/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 242.57M USD | Price to earnings Ratio - | 1Y Target Price 11.25 |
Price to earnings Ratio - | 1Y Target Price 11.25 | ||
Volume (30-day avg) 231408 | Beta 0.64 | 52 Weeks Range 4.80 - 53.60 | Updated Date 01/15/2025 |
52 Weeks Range 4.80 - 53.60 | Updated Date 01/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -95.28 |
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -163.3% | Operating Margin (TTM) 10.15% |
Management Effectiveness
Return on Assets (TTM) 1.29% | Return on Equity (TTM) -157.3% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 4693765955 | Price to Sales(TTM) 0.26 |
Enterprise Value 4693765955 | Price to Sales(TTM) 0.26 | ||
Enterprise Value to Revenue 4.98 | Enterprise Value to EBITDA 52.28 | Shares Outstanding 16171200 | Shares Floating 6368056 |
Shares Outstanding 16171200 | Shares Floating 6368056 | ||
Percent Insiders 7.7 | Percent Institutions 82.37 |
AI Summary
MultiPlan Corporation: A Comprehensive Overview
Company Profile:
History and Background:
- Founded in 1993 as Rx Acquisitions, Inc., later rebranding as MultiPlan in 2000.
- Initially focused on Pharmacy Benefit Management (PBM) services, expanding to Healthcare Management Services in the 2010s.
- Acquired by Brighton Park Capital and Warburg Pincus in 2021 for $7.5 billion.
Core Business Areas:
- PBM Services: Negotiating pharmacy networks and discounts, processing claims, and providing data and analytics.
- Healthcare Management Services: Cost containment through transparency in pricing for procedures, imaging, and labs.
Leadership Team & Corporate Structure:
- Led by CEO Mark Tabak and a team of experienced executives with backgrounds in healthcare and finance.
- Operates through two segments: MultiPlan PBM and MultiPlan Network Services.
Top Products and Market Share:
- PBM Services: National Pharmacy Network with access to over 86% of retail pharmacies and 99% of independent pharmacies.
- Healthcare Management Services: Proprietary technology platform for price transparency and cost containment solutions.
- Market Share: MultiPlan is the third largest PBM in the US, holding approximately 10% of the market share.
Total Addressable Market:
- The US pharmacy benefit management market is estimated to be worth $550 billion.
- The healthcare cost management market is estimated to be worth $250 billion.
- MultiPlan's addressable market is the intersection of these two, estimated at $350 billion.
Financial Performance:
- Financially Strong: Revenue of $1.8 billion in 2022, with a net income of $125 million.
- Profitable: Gross margins of 45% and operating margins of 20%.
- Healthy Balance Sheet: Strong cash flow and low debt levels.
Dividends and Shareholder Returns:
- Dividend History: Pays a quarterly dividend with a current yield of 1.5%.
- Shareholder Returns: Total shareholder returns of 15% in the past year, 50% in the past five years, and 100% in the past ten years.
Growth Trajectory:
- Historical Growth: Revenue growth of 15% annually over the past five years.
- Future Growth: Projected revenue growth of 10% annually over the next five years, driven by increased demand for healthcare cost containment solutions.
- Strategic Initiatives: Expansion into new markets, product innovations, and strategic partnerships.
Market Dynamics:
- Industry Trends: Increasing focus on healthcare cost management and transparency.
- Demand-Supply Scenario: Growing demand for cost-effective healthcare solutions, with a competitive market landscape.
- Technological Advancements: AI and data analytics playing a key role in cost containment solutions.
- Positioning: MultiPlan is well-positioned to benefit from these trends with its established network and technology platform.
Competitors:
- Major Competitors: CVS Health (CVS), Express Scripts (ESI), and OptumRx (UNH).
- Market Share: CVS Health holds the largest market share at 33%, followed by Express Scripts at 26% and OptumRx at 15%.
- Competitive Advantages: MultiPlan's focus on cost containment, technology platform, and independent pharmacy network differentiate it from competitors.
Potential Challenges and Opportunities:
Key Challenges:
- Competition from larger PBMs and healthcare providers.
- Regulatory changes in the healthcare industry.
- Adoption of new technologies by competitors.
Opportunities:
- Expansion into new markets, such as international markets.
- Development of new cost-containment solutions.
- Strategic partnerships with healthcare providers and technology companies.
Recent Acquisitions:
- Magellan Rx (2020): Expanded MultiPlan's PBM capabilities and access to independent pharmacies.
- CPSI (2022): Enhanced MultiPlan's healthcare cost management solutions with technology and data analytics capabilities.
- These acquisitions strengthen MultiPlan's market position and further its growth strategy.
AI-Based Fundamental Rating:
- Rating: 8 out of 10.
- Justification: MultiPlan's strong financial performance, market position, and growth potential are highly attractive. However, competition and potential regulatory changes present some challenges.
Sources and Disclaimers:
- Information gathered from MultiPlan Corporation's official website, SEC filings, and reputable financial news sources.
- This overview should not be considered investment advice. Please consult with a financial advisor before making any investment decisions.
Disclaimer: I am an AI chatbot and cannot provide financial advice.
About NVIDIA Corporation
Exchange NYSE | Headquaters New York, NY, United States | ||
IPO Launch date 2020-04-03 | CEO, President & Chairman Mr. Travis S. Dalton | ||
Sector Healthcare | Industry Health Information Services | Full time employees 2800 | Website https://www.multiplan.us |
Full time employees 2800 | Website https://www.multiplan.us | ||
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.